Calprotectin inhibits matrix metalloproteinases by sequestration of zinc

被引:95
作者
Isaksen, B [1 ]
Fagerhol, MK [1 ]
机构
[1] Ulleval Univ Hosp, Dept Immunol & Transfus Med, N-0407 Oslo, Norway
来源
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 2001年 / 54卷 / 05期
关键词
calprotectin; metalloproteinases; zinc;
D O I
10.1136/mp.54.5.289
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background/Aimss-Calprotectin, a 36 kDa protein present in neutrophil cytoplasm, has antimicrobial and apoptosis inducing activities, which are reversed by the addition of zinc. Matrix metalloproteinases (MMPs), a family of zinc dependent enzymes, are important in many normal biological processes including embryonic development, angiogenesis, and wound healing, but also pathological processes such as inflammation, cancer, and tissue destruction. The aim of this study was to investigate whether calprotectin can inhibit MMP activity, and whether such inhibition could be overcome by the addition of zinc. Methods-MMP activity was measured by the degradation of substrates precoated on to microwells, and visualised by Coomassie blue staining of residual substrate. Seven metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, and MMP-13) were teste against two substrates: gelatin and alpha -casein. Results-All MMPs except MMP-1 were active against gelatin, whereas MMP-7 was the only enzyme active against alpha -casein. The addition of calprotectin inhibited the activity of all the MMPs, but different concentrations of the protein, from 0.3 muM to > 11 muM, were necessary to produce a 50% inhibition of the MMPs. Inhibition by calprotectin was largely overcome by the addition of zinc. Conclusions-The findings suggest that calprotectin inhibits MMPs by sequestration of zinc. The data also suggest that MMPs have different affinities for zinc and that calprotectin has a lower zinc affinity than the MMPs.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 22 条
  • [1] PURIFICATION AND PARTIAL CHARACTERIZATION OF A HIGHLY IMMUNOGENIC HUMAN-LEUKOCYTE PROTEIN, THE L1-ANTIGEN
    DALE, I
    FAGERHOL, MK
    NAESGAARD, I
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 134 (01): : 1 - 6
  • [2] Fagerhol M. K., 1990, STIMULUS RESPONSE CO, P187
  • [3] FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393
  • [4] Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption
    Haro, H
    Crawford, HC
    Fingleton, B
    Shinomiya, K
    Spengler, DM
    Matrisian, LM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (02) : 143 - 150
  • [5] HIMELSTEIN BP, 1994, INVAS METAST, V14, P246
  • [6] Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta 1 release
    Imai, K
    Hiramatsu, A
    Fukushima, D
    Pierschbacher, MD
    Okada, Y
    [J]. BIOCHEMICAL JOURNAL, 1997, 322 : 809 - 814
  • [7] Degradation of interleukin 1 beta by matrix metalloproteinases
    Ito, A
    Mukaiyama, A
    Itoh, Y
    Nagase, H
    Thogersen, IB
    Enghild, JJ
    Sasaguri, Y
    Mori, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) : 14657 - 14660
  • [8] Johne B., 1997, Molecular Pathology, V50, P113, DOI 10.1136/mp.50.3.113
  • [9] Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin
    Loomans, HJ
    Hahn, BL
    Li, QQ
    Phadnis, SH
    Sohnle, PG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) : 812 - 814
  • [10] Matrix metalloproteinases
    Nagase, H
    Woessner, JF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) : 21491 - 21494